A Pharmaceutical Cannabis Stock with High Potential

In a week where stocks have seen sweeping declines, Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) shares are up 23.65% over the last five days. Analysts are optimistic about this stock and its potential recovery after the current market downturn. It’s a pick worth considering for an alternative portfolio. Zynerba is a pharmaceutical company that focuses on […]